课题基金 / 基金详情

Kidney injury as a determinant of macrophage phenotype and efficacy for treating chronic kidney disease (CKD)

Kidney injury as a determinant of macrophage phenotype and efficacy for treating chronic kidney disease (CKD)
肾损伤是巨噬细胞表型和治疗慢性肾病(CKD)疗效的决定因素
批准号:
nhmrc : 457345
负责人:
Dr Yiping Wang
金额:
$36.56万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31

项目摘要

项目成果

Dr Yiping Wang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic kidney disease (CKD) is a major cause of death and disability in the Australian population. Current treatments for CKD are non-specific and frequently ineffective. As a consequence, kidney failure progresses to the stage where patients require dialysis or tranplantation to remain alive. Every year more than 1700 Australians require kidney replacement therapy for this reason and many more die of kidney failure or its complications. Macrophage infiltration of kidneys is characteristic of CKD, and it has been assumed that macrophages cause damage. However, we have shown that certain types of macrophages can reduce kidney damage. This project will explore whether macrophage type can be switched from that causing damage to that reducing injury, with the aim of using this approach to treat CKD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Tregs Using Chimeric Antigen Receptors (CARs) for the Treatment of Autoimmune Renal Disease
  • 批准号:
    nhmrc : 1082317
  • 项目类别:
    Project Grants
  • 资助金额:
    $56.38万
  • 财政年份:
    2015
  • 负责人:
    Dr Yiping Wang
  • 依托单位:
Targeting Tregs Using Chimeric Antigen Receptors (CARs) for the Treatment of Autoimmune Renal Disease
  • 批准号:
    nhmrc : GNT1082317
  • 项目类别:
    Project Grants
  • 资助金额:
    $79.89万
  • 财政年份:
    2015
  • 负责人:
    Dr Yiping Wang
  • 依托单位:
Defining the role of the major subsets of renal mononuclear phogocytes
  • 批准号:
    nhmrc : 1061848
  • 项目类别:
    Project Grants
  • 资助金额:
    $40.96万
  • 财政年份:
    2014
  • 负责人:
    Dr Yiping Wang
  • 依托单位:
Therapeutic potential of peritoneal mononuclear phagocytes from peritoneal dialysis patients
  • 批准号:
    nhmrc : 1061785
  • 项目类别:
    Project Grants
  • 资助金额:
    $25.06万
  • 财政年份:
    2014
  • 负责人:
    Dr Yiping Wang
  • 依托单位:
国内基金
海外基金
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
  • 批准号:
    82371631
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    卢慕峻
  • 依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
  • 批准号:
    82371150
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    侯书乐
  • 依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
  • 批准号:
    82371373
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    沃雁
  • 依托单位:
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位: